View in EDS

Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab.

Saved in:
Bibliographic Details
Title: Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab.
Authors: Ko MY; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California., Talebi R; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania., Yu F; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Biostatistics, Fielding School of Public Health at the University of California Los Angeles, Los Angeles, California., Tseng VL; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California., Coleman AL; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California., Hosseini H; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California. Electronic address: hosseini@jsei.ucla.edu.
Source: Clinical therapeutics [Clin Ther] 2025 Aug; Vol. 47 (8), pp. 559-565. Date of Electronic Publication: 2025 May 17.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40383690
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ko+MY%22">Ko MY</searchLink>; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Talebi+R%22">Talebi R</searchLink>; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Yu+F%22">Yu F</searchLink>; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Biostatistics, Fielding School of Public Health at the University of California Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Tseng+VL%22">Tseng VL</searchLink>; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Coleman+AL%22">Coleman AL</searchLink>; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Hosseini+H%22">Hosseini H</searchLink>; Center for Community Outreach and Policy, Department of Ophthalmology, Stein & Doheny Eye Institutes, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California. Electronic address: hosseini@jsei.ucla.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227706726%22">Clinical therapeutics</searchLink> [Clin Ther] 2025 Aug; Vol. 47 (8), pp. 559-565. <i>Date of Electronic Publication: </i>2025 May 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Excerpta+Medica%22">Excerpta Medica </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7706726 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-114X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201492918%22">01492918 </searchLink><i>NLM ISO Abbreviation: </i>Clin Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40383690
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clinthera.2025.04.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 559
    Titles:
      – TitleFull: Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ko MY
      – PersonEntity:
          Name:
            NameFull: Talebi R
      – PersonEntity:
          Name:
            NameFull: Yu F
      – PersonEntity:
          Name:
            NameFull: Tseng VL
      – PersonEntity:
          Name:
            NameFull: Coleman AL
      – PersonEntity:
          Name:
            NameFull: Hosseini H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-114X
          Numbering:
            – Type: volume
              Value: 47
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical therapeutics
              Type: main
ResultId 1